Data Governance & Privacy

---

The Privacy Mandate in Modern Medicine

In the pursuit of cures for rare, complex, and high-velocity diseases, patient data is undeniably the most valuable asset we have—but it is also the most vulnerable. Historically, collaborative medical research has required health systems to extract, package, and transmit sensitive Patient Health Information (PHI) to centralized, third-party databases.

This legacy data-brokering model is fundamentally broken. It creates profound operational risks for hospitals, exponentially increases the surface area for cyberattacks, and severely complicates compliance with strict international privacy mandates like HIPAA in the US and GDPR in Europe. Ultimately, the fear of data breaches slows down life-saving research due to prolonged, adversarial legal negotiations between institutions.

At Regal Intel, we believe that advancing global medicine must never come at the expense of local privacy or institutional security. As a non-profit consortium, we have bypassed the traditional data-extraction model entirely. We operate on a fundamentally different, pragmatic diagnostics framework: The "Code-to-Data" Architecture.

Our Core Governance Pillars

• Local Processing (The "Code-to-Data" Approach): We respect the fundamental rule of data security: the safest way to protect patient records is to never move them. Instead of asking hospitals to export sensitive files to a central cloud, we deploy our secure diagnostics framework directly to the local clinical edge. Our systems process complex clinical patterns safely behind the institution's own firewall. By calculating continuous biological velocity locally, we extract only anonymized, mathematical diagnosis intelligence—never the raw patient files. The hospital retains absolute physical, legal, and operational custody of its PHI at all times.

• Verifiable Regulatory Auditability (ALCOA+ Compliance): For clinical research to be accepted by global regulators like the FDA and EMA, the data must be transparent, traceable, and fully auditable. We replace the "black box" of standard commercial analytics with a rigorous, transparent chain of custody. Every data transformation our diagnosis intelligence system performs is timestamped and secured with an immutable cryptographic ledger (SHA-256). This provides regulatory reviewers and FDA Bioresearch Monitoring (BIMO) inspectors with mathematically verifiable proof that the evidence used for Natural History models and Synthetic Control Arms is authentic, contemporaneous, and strictly unmanipulated.

• Architectural Isolation and Zero-Trust System Safety: We understand that hospital IT and security teams are stretched thin defending their networks against escalating threats. Participating in global research should never introduce new vulnerabilities or operational burdens. Our computational diagnostics frameworks are designed with zero-trust principles and operate within strictly isolated, containerized boundaries. By separating our analytical workload entirely from the hospital’s core Electronic Health Records (EHR) systems, we ensure that our presence does not interfere with daily clinical operations, cause system lag, or expose the broader hospital network to external risks.

• Ethical Stewardship for Patient Registries: Patient advocacy groups work tirelessly to build registries for their communities. We protect that hard work. When foundations plug into our sovereign network, our governance model ensures their data remains under their complete control. We simply provide the secure rails for that data to generate the high-fidelity diagnosis intelligence required to attract biotech investment, without ever commoditizing the patients themselves.

A Fiduciary Duty to Patient Communities

As a 501(c)(3) non-profit, Regal Intel acts as a neutral, trusted data fiduciary. We are not motivated by commercial data monetization, quarter-over-quarter shareholder returns, or proprietary lock-ins. We do not sell patient records, and we explicitly do not claim ownership over a hospital's insights or a foundation’s registry.

Our singular mandate is to provide the secure, enterprise-grade infrastructure necessary to help doctors, researchers, and families collaborate safely on rare, complex, and high-velocity diseases to find cures faster.